Check out our most popular compounded medications! Get Started
The Iodoquinol 140 mg/5 mL Oral Liquid is a specially compounded medication designed for oral use, offering a precise and manageable method of drug delivery. This liquid formulation is particularly beneficial for patients who experience difficulty swallowing pills, such as children and the elderly. Iodoquinol is an antiprotozoal and antibacterial agent used to treat amoebiasis, which includes conditions such as intestinal amoebiasis (amoebic dysentery) and hepatic amoebiasis (liver abscess caused by Entamoeba histolytica).
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
The Iodoquinol 140 mg/5 mL Oral Liquid is a custom-prepared medication designed for ease of administration and precise dosing. This formulation is particularly beneficial for patients who have difficulty swallowing pills, such as children and the elderly, or those with conditions that impair their ability to ingest solid forms of medication. Iodoquinol is an antiprotozoal and antibacterial agent, and in this liquid form, it is used to treat certain types of infections caused by amoebas, such as amoebic dysentery. This condition is characterized by severe diarrhea and is typically contracted in tropical areas with poor sanitation.
The liquid formulation ensures that the medication can be accurately measured to the prescribed dose, enhancing treatment efficacy and patient compliance. Iodoquinol works by halting the growth of the bacteria and protozoa that cause the infection, thereby alleviating the symptoms associated with the disease. It is important for patients to adhere to the prescribed dosage and duration of treatment to fully eradicate the infection and prevent the development of resistance.
Additionally, the medication may cause side effects such as nausea, diarrhea, headache, or dizziness. If any severe adverse reactions occur, patients should contact their healthcare provider immediately. As with all medications, it is crucial to discuss any potential drug interactions, underlying health conditions, or allergies with a healthcare professional before starting treatment with Iodoquinol Oral Liquid.
Bayview Pharmacy is committed to providing high-quality, personalized medication solutions. Our team of compounding pharmacists is available to answer any questions or concerns regarding the Iodoquinol 140 mg/5 mL Oral Liquid formulation. Please do not hesitate to reach out to us for further information or assistance.
Iodoquinol is an antiprotozoal and antibacterial agent used to treat infections caused by amoebas, such as amoebic dysentery, and it can also be used topically for certain skin conditions. When considering the use of iodoquinol 140 mg/5 mL oral liquid, it is important to be aware of potential drug interactions that may affect the efficacy of the medication or the safety of the patient.
One of the primary concerns with iodoquinol is its potential interaction with thyroid medications. Iodoquinol can interfere with thyroid function tests, leading to inaccurate results. Patients on thyroid medication should be closely monitored by their healthcare provider while taking iodoquinol. Additionally, iodoquinol may increase the risk of hypothyroidism or goiter, particularly in patients with pre-existing thyroid conditions or those on long-term therapy.
Concomitant use of iodoquinol with other medications that can affect the liver, such as acetaminophen, methotrexate, or isoniazid, may increase the risk of hepatotoxicity. It is important to monitor liver function tests in patients taking these combinations. Patients should also avoid alcohol consumption while on iodoquinol therapy, as this may exacerbate liver toxicity.
Patients taking anticoagulants like warfarin should be aware that iodoquinol may potentiate the effects of these drugs, increasing the risk of bleeding. Close monitoring of prothrombin time or INR is recommended, and dosage adjustments of the anticoagulant may be necessary.
Additionally, iodoquinol may interact with other antiprotozoal drugs, such as metronidazole or tinidazole, leading to an increased risk of neurological side effects. Caution is advised when these drugs are used concurrently, and patients should be monitored for signs of neurotoxicity.
It is also important to note that the absorption of iodoquinol may be reduced by the concomitant use of antacids or H2-receptor antagonists. To minimize this interaction, it is recommended to separate the administration of iodoquinol and these agents by at least two hours.
Patients should be advised to inform their healthcare provider of all medications, supplements, and herbal products they are taking before starting iodoquinol therapy. This includes over-the-counter medications, as they may also interact with iodoquinol. Healthcare providers should review the patient's medication regimen to identify and manage any potential interactions.
For any questions or concerns regarding the use of iodoquinol 140 mg/5 mL oral liquid, or to report any adverse effects or suspected drug interactions, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide guidance and support to ensure the safe and appropriate use of this medication.
Iodoquinol is an antiprotozoal and antibacterial agent that is used to treat infections caused by amoebas and certain bacteria. When formulated as a 140 mg/5 mL oral liquid, it provides a specific concentration of the active ingredient, iodoquinol, in a liquid vehicle. This liquid formulation is designed to be taken orally and is particularly beneficial for patients who have difficulty swallowing pills, such as children and the elderly, or for those who require precise dosage adjustments.
The mechanism of action of iodoquinol involves its interference with the metabolic processes of the protozoa and bacteria. It is believed to work by binding to proteins within the microorganisms, thereby disrupting their enzymatic systems and leading to their death. This action helps to clear the infection from the patient's body.
When administered, the iodoquinol oral liquid is absorbed from the gastrointestinal tract and exerts its effect locally in the intestines to combat the infection. The liquid form ensures that the medication is distributed evenly and allows for the active ingredient to come into direct contact with the site of infection. This formulation is also beneficial for patients who require a modified dose that may not be available in standard tablet or capsule forms.
The duration of treatment, frequency of dosing, and the total amount of medication to be taken should be determined based on the individual patient's condition and response to therapy. Additionally, patients should be monitored for any potential side effects, and prescribers should be aware of any contraindications or interactions with other medications the patient may be taking.
For those interested in using this iodoquinol 140 mg/5 mL oral liquid formulation, or for more detailed information about its use and potential side effects, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is available to answer any questions and provide the necessary guidance to ensure appropriate treatment.
Iodoquinol 140 mg/5 mL Oral Liquid is used to treat certain types of infections caused by amoebas, such as intestinal amoebiasis, which includes dysentery or diarrheal disease caused by amoebas.
This medication should be stored at room temperature, away from light and moisture. Keep the bottle tightly closed when not in use to prevent contamination or degradation of the medication.
Yes, our specially formulated Iodoquinol oral liquid is well-suited for both pediatric and geriatric patients, particularly those who have difficulty swallowing solid dosage forms.
Measure out the prescribed dose using the measuring device provided by your pharmacist or a medicine dosing spoon. Take the medication by mouth usually after meals as directed by your healthcare provider.
If you miss a dose, take it as soon as you remember unless it is near the time for the next dose. In that case, skip the missed dose and resume your regular dosing schedule. Do not double the dose to catch up.
Some common side effects include nausea, vomiting, diarrhea, and abdominal cramps. If any of these effects persist or worsen, inform your doctor or pharmacist promptly. Seek immediate medical attention if you experience serious side effects such as vision changes, ringing in the ears, or muscle weakness.
It is generally not recommended to mix medication with food or beverages unless specifically instructed by your healthcare provider, as certain substances can interact with the medication and affect its effectiveness.
The safety of Iodoquinol during pregnancy or breastfeeding has not been fully established. You should only use this medication during pregnancy if clearly needed and directed by your healthcare provider. If you are breastfeeding, discuss the risks and benefits with your doctor before starting treatment.
The duration of treatment with Iodoquinol oral liquid will depend on your medical condition and response to therapy. It is important to complete the prescribed course of medication even if your symptoms disappear, to ensure that the infection is fully treated.
As with many medications, Iodoquinol can cause dizziness or other symptoms that could affect your ability to drive or operate heavy machinery. It is advised to understand how this medication affects you before engaging in such activities.
There may be dietary restrictions or interactions with other medications while taking Iodoquinol. Consult with your healthcare provider for advice on any specific food or medication interactions that may be relevant to your treatment.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
